Biotinylated Human GLP1R Protein, His,Avitag™ (HPLC verified)

Customer Reviews
Cat. No. / Size
Price
Qty
GLR-H82E3-25ug
$415.00
GLR-H82E3-200ug
$1705.00
ETA of in-stock products:2 business days

Product Details

  • Synonyms

    GLP-1-R, GLP-1R, glucagon like peptide 1 receptor

  • Source

    Biotinylated Human GLP1R, His,Avitag (GLR-H82E3) is expressed from human 293 cells (HEK293). It contains AA Ala 21 - Glu 139 (Accession # P43220-1).

    Predicted N-terminus: Ala 21

    Request for sequence
  • Molecular Characterization

    GLP1R Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 17.3 kDa. The protein migrates as 30-34 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    GLP1R SDS-PAGE

    Biotinylated Human GLP1R, His,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-HPLC

    GLP1R SEC-HPLC

    The purity of Biotinylated Human GLP1R, His,Avitag (Cat. No. GLR-H82E3) was greater than 85% as determined by SEC-HPLC.

  • Bioactivity-ELISA

     GLP1R ELISA

    Immobilized Biotinylated Human GLP1R Protein, His,Avitag (Cat. No. GLR-H82E3) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-GLP-R1 Antibody with a linear range of 0.5-31 ng/mL (QC tested).

    Protocol
  • Bioactivity-SPR

     GLP1R SPR

    Anti-GLPR1 antibody captured on Protein A Chip can bind Biotinylated Human GLP1R, His,Avitag (Cat. No. GLR-H82E3) with an affinity constant of 13.1 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  •  GLP1R SPR

    Biotinylated Human GLP1R, His,Avitag (Cat. No. GLR-H82E3) immobilized on CM5 Chip can bind GLP-1 (7-37) with an affinity constant of 1.33 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  • Bioactivity-BLI

     GLP1R BLI

    Loaded Biotinylated Human GLP1R, His,Avitag (Cat. No. GLR-H82E3) on NTA Biosensor, can bind GLP-1 (7-37) with an affinity constant of 1.40 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

This gene encodes a 7-transmembrane protein that functions as a receptor for glucagon-like peptide 1 (GLP-1) hormone, which stimulates glucose-induced insulin secretion. This receptor, which functions at the cell surface, becomes internalized in response to GLP-1 and GLP-1 analogs, and it plays an important role in the signaling cascades leading to insulin secretion. It also displays neuroprotective effects in animal models. Polymorphisms in this gene are associated with diabetes. The protein is an important drug target for the treatment of type 2 diabetes and stroke.

Recent Advances

 
Drug Development Progress
  • English Name:

    Glucagon-like peptide-1

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    13 Details

  • Highest Development Stage:

    Phase 3 Clinical

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland